Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rowley

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Genome Medicine|August 11, 2015
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursorsGeorgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Blood|October 1, 1995
Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategyC J Formstone, A I Wacey, L P Berg, et al.
Genome Medicine|January 14, 2017
Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursorsGeorgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2015
Copy number analysis of ductal carcinoma in situ with and without recurrenceKylie L Gorringe, Sally M Hunter, Jia-Min Pang, et al.
Scientific Reports|October 13, 2015
Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer contextElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Breast Cancer Research : BCR|January 11, 2018
Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPsNa Li, Simone M Rowley, Ella R Thompson, et al.
Journal of Medicinal Chemistry|May 4, 2001
3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonistsM Rowley, D J Hallett, S Goodacre, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 27, 2018
Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibilitySimone M Rowley, Lyon Mascarenhas, Lisa Devereux, et al.
Journal of the National Cancer Institute|October 31, 2022
Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variantsBelle W X Lim, Na Li, Sakshi Mahale, et al.
NPJ Breast Cancer|June 12, 2021
Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control studyNa Li, Belle W X Lim, Ella R Thompson, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Genome Medicine|August 11, 2015
Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursorsGeorgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Blood|October 1, 1995
Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategyC J Formstone, A I Wacey, L P Berg, et al.
Genome Medicine|January 14, 2017
Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursorsGeorgina L Ryland, Sally M Hunter, Maria A Doyle, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 1, 2015
Copy number analysis of ductal carcinoma in situ with and without recurrenceKylie L Gorringe, Sally M Hunter, Jia-Min Pang, et al.
Scientific Reports|October 13, 2015
Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer contextElla R Thompson, Kylie L Gorringe, Simone M Rowley, et al.
Breast Cancer Research : BCR|January 11, 2018
Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPsNa Li, Simone M Rowley, Ella R Thompson, et al.
Journal of Medicinal Chemistry|May 4, 2001
3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonistsM Rowley, D J Hallett, S Goodacre, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 27, 2018
Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibilitySimone M Rowley, Lyon Mascarenhas, Lisa Devereux, et al.
Journal of the National Cancer Institute|October 31, 2022
Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variantsBelle W X Lim, Na Li, Sakshi Mahale, et al.
NPJ Breast Cancer|June 12, 2021
Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control studyNa Li, Belle W X Lim, Ella R Thompson, et al.
Pageof 21